Table 3.
Model assumptions
Number | Assumption | Clarification |
---|---|---|
1 | All compounds influence the production rates of HR, SV or TPR rather than the dissipation rates. | This assumption is based on the MoA of the selected compounds (Table 4). |
2 | For compounds for which the maximum effect was not observed, complete inhibition (i.e. Emax = 1) was assumed at infinite concentrations to ensure identification of the EC50 parameter. | The validity of this assumption was evaluated for amlodipine using the basic CVS model (Snelder et al., 2013a). The influence of different values of the Emax (i.e. Emax = 0.8) on the estimates of the system parameters was tested. |
3 | The PK does not differ between rat strains and can be scaled between rabbit and rat on the basis of an allometric function (West et al., 1999; Anderson and Holford, 2009). | Although published information on the PK of all selected compounds was available, the PK was often evaluated in different rat strains and, for prazosin, even in a different species (rabbit). |